Teachers Retirement System of Kentucky Reduces Vertex Pharmaceuticals Stake

The pension fund sold over 25,000 shares of the pharmaceutical company in Q3 2025.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Teachers Retirement System of The State of Kentucky, a major institutional investor, reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) by 37.5% during the third quarter of 2025, according to a recent 13F filing with the Securities & Exchange Commission. The fund now owns 42,581 shares of the pharmaceutical company's stock, down from 68,180 shares previously.

Why it matters

Vertex Pharmaceuticals is a leading biotech company focused on developing treatments for serious diseases like cystic fibrosis. The reduction in stake by a major institutional investor like the Kentucky teachers' pension fund could signal a shift in sentiment around the company's prospects or valuation.

The details

According to the 13F filing, Teachers Retirement System of The State of Kentucky sold 25,599 shares of Vertex Pharmaceuticals during the third quarter. The fund's remaining 42,581 shares were valued at $16,676,000 at the end of the reporting period.

  • The stake reduction occurred during Q3 2025.

The players

Teachers Retirement System of The State of Kentucky

A major institutional investor and pension fund that manages retirement assets for Kentucky public school teachers.

Vertex Pharmaceuticals Incorporated

A Boston-based biotechnology company focused on developing treatments for serious diseases like cystic fibrosis.

Got photos? Submit your photos here. ›

The takeaway

The reduction in stake by a large institutional investor like the Kentucky teachers' pension fund could signal a shift in sentiment around Vertex Pharmaceuticals' prospects or valuation, though the specific reasons behind the move are unclear from the available information.